StockData
Neogen Corp logo

Neogen Corp (NEOG) bonds

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Debt

Borrowings on the balance sheet, Aug 31, 2026

Total debt
$1.55B
$780.00M due within a year
Net debt
$1.38B
After $172.00M of cash
Implied interest rate
1.94%
FY2026 interest ÷ average debt
Interest coverage
-0.9×
FY2026 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at May 31, 2025

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Neogen's 10-Q for the period ended Aug 31, 2026

Neogen's filings do not break debt down by note

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed. The repayment schedule above comes from the same report.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
Revolving Credit Facility–$48.50M

See a number that looks wrong?